Michael Keating is a registered pharmacist and the current Director of Global Product Development at Pfizer, where they lead clinical execution of complex Phase 2 and 3 studies. Previously, Michael held various roles in medical communication and science liaison positions at companies like Alexion Pharmaceuticals, Actelion Pharmaceuticals, and Wyeth Pharmaceuticals, focusing on infectious diseases, oncology, and metabolic disorders. Michael earned a PharmD and a BS in Biology from Campbell University and has received recognition for excellence in clinical development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices